We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Lineage Cell Therapeutics
LCTX
$257M
| $416K | ﹤0.01% |
263,066
-352,700
| -57% | -$465K |
|
2002
Ero Copper
ERO
$2.73B
| $414K | ﹤0.01% |
49,100
-79,800
| -62% | -$995K |
|
2003
Supernus Pharmaceuticals
SUPN
$2.73B
| $414K | ﹤0.01% |
14,300
-16,400
| -53% | -$470K |
|
2004
Melco Resorts & Entertainment
MLCO
$2.18B
| $413K | ﹤0.01% |
71,900
+43,600
| +154% | +$256K |
|
2005
PC Connection
CNXN
$2.05B
| $410K | ﹤0.01% |
+9,300
| New | +$441K |
|
2006
LifeMD
LFMD
$187M
| $408K | ﹤0.01% |
200,200
-71,700
| -26% | -$178K |
|
2007
Capital Bancorp
CBNK
$591M
| $406K | ﹤0.01% |
18,700
-2,200
| -11% | -$49.1K |
|
|
MODV
2008
DELISTED
ModivCare
MODV
| $406K | ﹤0.01% |
4,800
| – | – |
|
|
SEEL
2009
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $405K | ﹤0.01% |
155
-139
| -47% | -$362K |
|
2010
Ouster
OUST
$2.36B
| $404K | ﹤0.01% |
24,930
+16,670
| +202% | +$467K |
|
|
SPNS
2011
DELISTED
Sapiens International
SPNS
| $404K | ﹤0.01% |
+16,700
| New | +$404K |
|
2012
Townsquare Media
TSQ
$106M
| $404K | ﹤0.01% |
49,300
+12,200
| +33% | +$126K |
|
2013
West Bancorporation
WTBA
$472M
| $404K | ﹤0.01% |
16,600
-1,200
| -7% | -$29.9K |
|
2014
CNX Resources
CNX
$4.77B
| $403K | ﹤0.01% |
24,500
-226,700
| -90% | -$4.64M |
|
|
IVAC
2015
DELISTED
Intevac Inc
IVAC
| $403K | ﹤0.01% |
83,200
+28,600
| +52% | +$146K |
|
2016
Associated Banc-Corp
ASB
$5.78B
| $402K | ﹤0.01% |
+22,000
| New | +$445K |
|
|
CSW
2017
CSW Industrials
CSW
$4.78B
| $402K | ﹤0.01% |
+3,900
| New | +$416K |
|
2018
Puma Biotechnology
PBYI
$407M
| $402K | ﹤0.01% |
141,000
+48,800
| +53% | +$121K |
|
2019
Neuronetics
STIM
$126M
| $401K | ﹤0.01% |
124,900
-7,400
| -6% | -$21.5K |
|
2020
Acushnet Holdings
GOLF
$6.08B
| $400K | ﹤0.01% |
9,600
-11,700
| -55% | -$482K |
|
2021
Tidewater
TDW
$3.91B
| $400K | ﹤0.01% |
18,954
+7,000
| +59% | +$161K |
|
2022
Kanzhun
BZ
$7.03B
| $399K | ﹤0.01% |
15,200
+6,900
| +83% | +$153K |
|
2023
Neurogene
NGNE
$691M
| $399K | ﹤0.01% |
19,380
+4,930
| +34% | +$120K |
|
2024
Vital Farms
VITL
$569M
| $398K | ﹤0.01% |
45,500
+19,600
| +76% | +$209K |
|
2025
Superior Group of Companies
SGC
$195M
| $394K | ﹤0.01% |
+22,200
| New | +$382K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.